Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Mass.
Department of Emergency Medicine, Obama Municipal Hospital, Obama, Fukui, Japan.
J Allergy Clin Immunol Pract. 2013 Sep-Oct;1(5):509-15.e1-3. doi: 10.1016/j.jaip.2013.05.001. Epub 2013 Jun 21.
Little is known about the quality of acute asthma care in emergency departments (EDs) outside of North America.
We evaluated concordance of acute asthma management in Japanese EDs with recommendations in the 2007 National Institutes of Health asthma guidelines and investigated whether guideline concordance was associated with risk of hospital admission.
We conducted a multicenter chart review study in 23 EDs across Japan. We identified ED patients aged 18 to 54 years with acute asthma between 2009 and 2011. Concordance with evidence-based guideline recommendations was evaluated by using item-by-item quality measures and composite concordance scores both at patient and ED levels. These scores ranged from 0 to 100.
Among 1380 patients, the median age was 35 years and 11% were hospitalized. Overall guideline concordance score was suboptimal both at the patient level (mean ± SD, 72 ± 14) and ED level (mean ± SD, 72 ± 6). Specifically, asthma care at the patient level was suboptimal in several areas: inhaled anticholinergics in ED (2%), systemic corticosteroid in ED (56%) and at discharge (36%), and peak flow assessment (9%). A multivariable model that adjusted for severity at presentation and several ED characteristics showed that higher guideline concordance was associated with significantly lower risk of hospital admission (odds ratio, 0.70 per 10-unit increase in composite score; 95% CI, 0.62-0.79 per 10-unit increase in composite score).
The management of acute asthma in Japanese EDs is suboptimal. Greater concordance with guideline-recommended management might reduce unnecessary hospitalizations. Knowledge translation initiatives are warranted to increase adherence with best practice in acute asthma management.
北美的以外的急诊部门(ED)中,鲜少有人了解急性哮喘治疗的质量。
我们评估了日本 ED 中急性哮喘管理与 2007 年美国国立卫生研究院哮喘指南的建议的一致性,并研究了指南一致性是否与住院风险相关。
我们在日本的 23 个 ED 中进行了一项多中心图表回顾研究。我们确定了 2009 年至 2011 年间患有急性哮喘且年龄在 18 至 54 岁的 ED 患者。通过使用逐项质量指标和患者及 ED 水平的综合一致性评分来评估与基于证据的指南建议的一致性。这些分数范围从 0 到 100。
在 1380 名患者中,中位数年龄为 35 岁,11%的患者住院。患者水平(平均 ± 标准差,72 ± 14)和 ED 水平(平均 ± 标准差,72 ± 6)的总体指南一致性评分均不理想。具体而言,患者层面的哮喘治疗在几个方面都不理想:ED 中的吸入抗胆碱能药物(2%)、ED 和出院时的全身皮质类固醇(56%和 36%)以及峰流速评估(9%)。调整了就诊时严重程度和几个 ED 特征的多变量模型显示,更高的指南一致性与住院风险显著降低相关(比值比,每增加 10 个单位的复合评分降低 0.70;95%置信区间,每增加 10 个单位的复合评分降低 0.62-0.79)。
日本 ED 中急性哮喘的管理不理想。与指南推荐的管理方法更加一致可能会减少不必要的住院治疗。有必要开展知识转化活动,以提高对急性哮喘管理最佳实践的依从性。